Global Drug Infusion Systems Market

Report ID : 1090 | Published : 2021-07-23 | Pages: 140 | Format:

Drug infusion systems are used across pharmacological therapies to administer various drugs including antibiotics, insulin, chemotherapy drugs, painkillers, intravenously or through non-oral routes, like epidural routes and intramuscular injections in a controlled manner.

The Global drug infusion system market is expected to offer lucrative growth in the coming years owing to the increasing prevalence of chronic diseases and rising geriatric population across the globe.

The rise in chronic diseases has led to high demand for better medicines and facilities. For instance, as per the latest estimates by the IDF Diabetes Atlas Ninth edition 2019, around 463 million people aged between 20-79 years were living with diabetes in 2019; the number is estimated to reach 700 million by 2045. Moreover, the prevalence of genetic diseases and cancer has witnessed an upsurge in recent years. For the advanced and continued care of the patients, the drug infusion systems are being extensively used in hospitals and critical care centers.

On the other side, the high cost of the drug infusion system and stringent government regulations are expected to restrain the market's growth during the forecast period.

The Global Drug infusion systems market is segmented on the basis of product type, application, and region. Based on the product type, the market is divided into large volume infusion systems, patient-controlled analgesia, elastomeric infusion pumps, insulin infusion pumps, syringe infusion systems, implantable infusion systems, ambulatory infusion systems, and enteral infusion systems. On the basis of application, the market is divided into oncology/chemotherapy, diabetes, analgesia, nutrition, haematology, pediatrics, and other applications.

Based on the region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. North America held the largest share of the market in 2019, followed by Europe and Asia Pacific. However, the Asia Pacific is projected to have the highest growth rate during the forecast period.

The key players operating in the market include Acromed AG, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Caesarea Medical Electronics Ltd., Debiotech S.A., Flowonix Medical Inc., Fresenius SE & Co. KGaA, Halyard Health, Inc., ICU Medical Inc., IRADIMED CORPORATION, Insulet Corporation, Medtronic, MOOG, Inc., Smiths Group plc, Tandem Diabetes Care, Inc., Terumo Corporation and Zyno Medical, LLC among others.

  • Acromed AG
  • Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company,
  • Caesarea Medical Electronics Ltd.
  • Debiotech S.A.
  • Flowonix Medical Inc.
  • Fresenius SE & Co. KGaA
  • Halyard Health, Inc.
  • ICU Medical Inc.
  • IRADIMED CORPORATION
  • Insulet Corporation
  • Medtronic
  • MOOG, Inc.
  • Smiths Group plc
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Zyno Medical, LLC
  • Other Prominent Players

Global Drug Infusion Systems Market Segmentation:

 

Global Drug Infusion Systems Market Revenue (US$ Mn), by Product Type, 2019–2030

  • Large Volume Infusion Systems
  • Patient-Controlled Analgesia
  • Elastomeric Infusion Pumps
  • Insulin Infusion Pumps
  • Syringe Infusion Systems
  • Implantable Infusion Systems
  • Ambulatory Infusion Systems
  • Enteral Infusion Systems

Global Drug Infusion Systems Market Revenue(US$ Mn), by Applications, 2019–2030

  • Oncology/Chemotherapy
  • Diabetes
  • Analgesia
  • Nutrition
  • Haematology
  • Paediatrics
  • Other Applications

Global Drug Infusion Systems Market Revenue(US$ Mn),  by Region, 2019–2030

North America Drug Infusion Systems Market Revenue (US$ Mn) by Country, 2019–2030

  • U.S.
  • Canada

Europe Drug Infusion Systems Market Revenue (US$ Mn), by Country, 2019–2030

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Drug Infusion Systems Market Revenue (US$ Mn), by Country, 2019–2030

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Drug Infusion Systems Market Revenue (US$ Mn), by Country, 2019–2030

  • Mexico
  • Rest of Latin America

Middle East & Africa Drug Infusion Systems Market Revenue (US$ Mn), by Country, 2019–2030

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients